InvestorsHub Logo
Followers 13
Posts 1223
Boards Moderated 0
Alias Born 04/16/2024

Re: None

Tuesday, 07/30/2024 5:21:33 PM

Tuesday, July 30, 2024 5:21:33 PM

Post# of 25
Going to explode on the next readout

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PASG News